Papers
2
Total Citations
41
H-Index
2
About
Dr. Weimin Xie is a leading figure in gynecologic oncology, with a focused expertise in the comparative effectiveness of robotic surgical techniques for endometrial cancer. Her major contributions lie in synthesizing high-level evidence through systematic reviews and meta-analyses, directly informing clinical decision-making. Her seminal 2016 work, "Robot-assisted surgery versus conventional laparoscopic surgery for endometrial cancer," a highly cited paper with 39 citations, established a foundational comparison between these two minimally invasive approaches. Building on this, Dr. Xie’s most recent and forward-looking meta-analysis (2025) tackles the next frontier: comparing robotic single-site hysterectomy (RSSH) against robotic multiport hysterectomy (RMPH). This work, which systematically evaluates the safety and efficacy of these advanced platforms, demonstrates her commitment to refining surgical precision and patient outcomes. By rigorously analyzing databases like PubMed and Cochrane, Dr. Xie provides the critical, data-driven insights that guide surgeons in adopting the most effective, least invasive technologies for treating endometrial cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2